Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Innovaderma stock

IDP.L
GB00BT9PTW34
A14TML

Price

0.29
Today +/-
+0
Today %
+0 %
P

Innovaderma stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Innovaderma stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Innovaderma stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Innovaderma stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Innovaderma's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Innovaderma Stock Price History

DateInnovaderma Price
5/31/20220.29 undefined
5/30/20220.29 undefined

Innovaderma Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Innovaderma, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Innovaderma from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Innovaderma’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Innovaderma. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Innovaderma’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Innovaderma’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Innovaderma’s growth potential.

Innovaderma Revenue, EBIT and net profit per share

DateInnovaderma RevenueInnovaderma EBITInnovaderma Net Income
2024e11.54 M undefined108,000 undefined87,260.84 undefined
2023e11.77 M undefined180,000 undefined139,283.96 undefined
2022e12.36 M undefined309,000 undefined228,991.85 undefined
202110.21 M undefined-1.88 M undefined-2.25 M undefined
202013.21 M undefined-3.85 M undefined-4.56 M undefined
201912.85 M undefined1.41 M undefined1.01 M undefined
201810.7 M undefined670,000 undefined410,000 undefined
20178.86 M undefined1.03 M undefined688,950 undefined
20164.3 M undefined241,850 undefined177,750 undefined
2015580,560 undefined-498,905 undefined-498,900 undefined

Innovaderma Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (k)EBIT MARGIN (%)NET INCOME (k)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20152016201720182019202020212022e2023e2024e
04810121310121111
--100.0025.0020.008.33-23.0820.00-8.33-
-50.0062.5060.0066.6738.4650.00---
0256855000
001,00001,000-3,000-1,000000
--12.50-8.33-23.08-10.00---
00001,000-4,000-2,000000
------500.00-50.00---
7.4510.411.5113.8914.614.6417.45000
----------
Details

Keystats

ⓘ

Revenue and Growth

The Innovaderma Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Innovaderma is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (k)INVENTORIES (M)OTHER CURRENT LIAB. (k)CURRENT ASSETS (M)TANGIBLE ASSETS (k)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (k)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (k)DEFERRED TAXES (k)OTHER LIAB. (M)LONG-T. LIABILITIES (k)DEBT (M)TOTAL CAPITAL (M)
2015201620172018201920202021
             
00.130.221.912.051.242.34
01.141.781.923.31.091.57
016.9817.4200190130
00.642.262.872.361.271.81
8.2520.6684.95180300320200
0.011.944.366.888.014.116.05
08.28127.25050150230
0000000
0000000
02.013.655.694.330.120.23
00002.250.440.44
0101.88129.941902503800
02.123.95.936.881.090.9
0.014.058.2712.8114.895.26.95
             
01.381.571.731.741.742.86
01.413.898.228.298.2911.19
0-1,136.29-627.39-180570-8,580-10,970
0105.04-53.69-160-170260280
0000000
01.754.789.6110.431.713.36
01.442.422.312.742.242.25
000001.131.21
00.170.50.641.420.10.09
0000000
0000000
01.612.922.954.163.473.55
0621.78404.8510000
04.1900000
0000000
0625.97404.8510000
02.243.332.964.163.473.55
03.998.112.5714.595.186.91
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Innovaderma provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Innovaderma's financial health and stability.

Assets

Innovaderma's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Innovaderma must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Innovaderma after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Innovaderma's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (k)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (k)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2015201620172018201920202021
00000-5-1
0000000
0000000
0000020
000001,0000
0000000
0000000
00001,0000-2,000
000-2000
000-2000
0000000
0000000
0000000
0014003
0013004
-------
0000000
0001112
0000000
0000000

Innovaderma stock margins

The Innovaderma margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Innovaderma. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Innovaderma.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Innovaderma's sales revenue. A higher gross margin percentage indicates that the Innovaderma retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Innovaderma's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Innovaderma's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Innovaderma's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Innovaderma. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Innovaderma's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Innovaderma Margin History

Innovaderma Gross marginInnovaderma Profit marginInnovaderma EBIT marginInnovaderma Profit margin
2024e56.71 %0.94 %0.76 %
2023e56.71 %1.53 %1.18 %
2022e56.71 %2.5 %1.85 %
202156.71 %-18.41 %-22.04 %
202045.19 %-29.14 %-34.52 %
201962.96 %10.97 %7.86 %
201856.92 %6.26 %3.83 %
201762.95 %11.62 %7.78 %
201657.44 %5.62 %4.13 %
201567 %-85.94 %-85.93 %

Innovaderma Stock Sales Revenue, EBIT, Earnings per Share

The Innovaderma earnings per share therefore indicates how much revenue Innovaderma has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Innovaderma earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Innovaderma's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Innovaderma’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Innovaderma's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Innovaderma Revenue, EBIT and net profit per share

DateInnovaderma Sales per ShareInnovaderma EBIT per shareInnovaderma Earnings per Share
2024e0.41 undefined0 undefined0 undefined
2023e0.42 undefined0 undefined0 undefined
2022e0.44 undefined0 undefined0.01 undefined
20210.59 undefined-0.11 undefined-0.13 undefined
20200.9 undefined-0.26 undefined-0.31 undefined
20190.88 undefined0.1 undefined0.07 undefined
20180.77 undefined0.05 undefined0.03 undefined
20170.77 undefined0.09 undefined0.06 undefined
20160.41 undefined0.02 undefined0.02 undefined
20150.08 undefined-0.07 undefined-0.07 undefined

Innovaderma business model

Innovaderma PLC is a UK-based company that was founded in 2014. It specializes in the development and marketing of natural cosmetic products. The company has quickly made a name for itself in the cosmetics industry through its continuous innovation and market knowledge. Innovaderma's business model is focused on marketing products based on natural ingredients. The company places great value on quality, effectiveness, and high customer orientation. Its goal is to offer high-quality and affordable cosmetic products that are specifically tailored to the needs of its customers. The company operates various divisions to reach its target audiences more effectively and broaden its business. These include: - Skinny Tan: Skinny Tan is a division of the company that specializes in the development and marketing of self-tanning products. The products are based on natural ingredients and provide excellent results without compromising health. - Roots: Roots is a division that specializes in natural hair care products. The products are based on natural ingredients and are free from parabens, sulfates, and other harmful chemicals. - Stevie K: Stevie K is another division that specializes in marketing skincare products for men. The products are based on natural ingredients and provide comprehensive care tailored to the needs of male skin. Innovaderma offers various skincare and hair care products such as shampoos, conditioners, sunscreens, self-tanners, and lotions. The products are known for their high quality and strong focus on customer needs. Innovaderma prides itself on developing its products based on research and development. The company has an experienced research team that continuously works on new formulations to ensure that its products are always one step ahead in the market. The company also has a strong online presence, which allows it to reach a larger target audience and sell its products worldwide. This focus on online sales and e-commerce has helped the company remain successful even amidst the Covid-19 pandemic. Overall, Innovaderma is an emerging force in the cosmetics industry that has quickly gained significance through continued innovation and consistent customer orientation. The company is expected to continue growing and become a prominent player in the natural cosmetics industry. Innovaderma is one of the most popular companies on Eulerpool.com.

Innovaderma SWOT Analysis

Strengths

Innovaderma PLC has several key strengths that contribute to its success:

  • Strong portfolio of recognized beauty and personal care brands
  • Extensive distribution network in multiple countries
  • Experienced and knowledgeable management team
  • Consistent focus on research and development to drive innovation
  • Established relationships with suppliers and retailers

Weaknesses

Despite its strengths, Innovaderma PLC also faces certain weaknesses:

  • Relatively small market share compared to larger competitors
  • Dependence on a limited number of key suppliers
  • Limited presence in certain geographic regions
  • Higher production costs in comparison to some competitors
  • Challenges in keeping up with rapidly changing consumer trends

Opportunities

Innovaderma PLC can capitalize on the following opportunities:

  • Expanding into emerging markets to drive growth
  • Growing demand for natural and organic beauty products
  • Increased consumer focus on health and wellness
  • Advancements in technology for product development and marketing
  • Potential for strategic partnerships and collaborations

Threats

Innovaderma PLC should be wary of the following threats in the industry:

  • Intense competition from larger beauty and personal care brands
  • Changing regulations and compliance requirements
  • Disruptions in supply chains due to global events or natural disasters
  • Economic downturns and fluctuations in consumer spending habits
  • Rapidly evolving consumer preferences and shifting market trends

Innovaderma Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Innovaderma historical P/E ratio, EBIT multiple, and P/S ratio

Innovaderma shares outstanding

The number of shares was Innovaderma in 2023 — This indicates how many shares 17.45 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Innovaderma earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Innovaderma's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Innovaderma’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Innovaderma's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for Innovaderma.

Innovaderma shareholders

%
Name
Stocks
Change
Date
17.99386 % Ward (Mark Michael)5,049,07604/8/2022
10.94105 % Edale Capital LLP3,070,0581,075,2854/4/2022
3.56379 % Gourlay (Scott Charles)1,000,000800,0004/11/2022
3.14922 % McDowell (Roger Steven)883,671153,6714/13/2022
2.36892 % Ferguson (Louise Cara)664,718664,7183/31/2022
2.33965 % Walker Crips Investment Management Limited656,505459,0443/30/2022
1.95509 % Coats (William Neil Stewart)548,598158,0214/12/2022
1.53243 % Yeatman (Paul R)430,00004/11/2022
1.43792 % Hoon (Lee Sang)403,480403,4802/15/2021
1.20440 % Zamar (Antonios Camille)337,95604/12/2022
1
2
3
4

Innovaderma Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
CK Hutchison Holdings Stock
CK Hutchison Holdings
SupplierCustomer0,860,420,56-0,20-0,03-0,42
Walgreens Boots Alliance Stock
Walgreens Boots Alliance
SupplierCustomer0,050,370,220,720,66-0,66
1

Most common questions regarding Innovaderma

What values and corporate philosophy does Innovaderma represent?

Innovaderma PLC represents values of innovation, excellence, and consumer satisfaction in the beauty and personal care industry. The company is committed to delivering high-quality products that fulfill consumers' needs and preferences. Innovaderma focuses on research and development, constantly striving to bring cutting-edge solutions and advancements to the market. With a customer-centric approach, the company emphasizes product effectiveness, safety, and sustainability. Innovaderma PLC believes in fostering strong relationships with its customers, ensuring transparency, trust, and reliability. By consistently striving for excellence and staying ahead of market trends, Innovaderma PLC has established itself as a leading player in the beauty industry.

In which countries and regions is Innovaderma primarily present?

Innovaderma PLC is primarily present in several countries and regions. The company has a strong presence in the United Kingdom, where it is headquartered. Additionally, Innovaderma has a significant market presence in Australia, New Zealand, South Africa, and Europe. With its innovative range of skincare and personal care products, Innovaderma has successfully expanded its reach to various countries, establishing a global presence in the beauty and wellness industry.

What significant milestones has the company Innovaderma achieved?

Innovaderma PLC, a renowned company in the stock market, has achieved remarkable milestones in its journey. The company has successfully expanded its global presence, gaining popularity for its innovative skincare and beauty products. Innovaderma PLC has also exhibited consistent growth in revenue and established strategic partnerships with top retailers worldwide. The company's commitment to research and development has led to the introduction of cutting-edge technologies in the beauty industry. With an exceptional track record, Innovaderma PLC continues to thrive and deliver superior value to its shareholders and customers alike.

What is the history and background of the company Innovaderma?

Innovaderma PLC is a renowned company specialized in the development, manufacturing, and distribution of innovative beauty and personal care products. Established in 2012, Innovaderma has gained significant recognition for its commitment to providing high-quality and effective solutions for various beauty concerns. The company's portfolio comprises internationally acclaimed brands like Skinny Tan, Charles + Lee, and Roots Double Effect. With a strong focus on research and development, Innovaderma continuously strives to introduce cutting-edge skincare and haircare solutions to the market. Over the years, Innovaderma PLC has successfully built a loyal customer base globally, thanks to its dedication to delivering exceptional results and customer satisfaction.

Who are the main competitors of Innovaderma in the market?

The main competitors of Innovaderma PLC in the market include prominent brands such as L'Oreal, Procter & Gamble, Unilever, and Estee Lauder. These global companies also specialize in the beauty and personal care industry, offering a wide range of products and competing for market share with Innovaderma PLC.

In which industries is Innovaderma primarily active?

Innovaderma PLC is primarily active in the health and beauty industry. The company specializes in the research, development, and sale of innovative cosmetic products. With a focus on delivering effective solutions, Innovaderma PLC offers a diverse range of high-quality skincare, haircare, and personal care products. By utilizing advanced technologies and ingredients, the company strives to address various beauty concerns and provide consumers with nourishing and transformative experiences. Innovaderma PLC remains committed to enhancing individual confidence and well-being through its exceptional product offerings in the health and beauty sector.

What is the business model of Innovaderma?

The business model of Innovaderma PLC is focused on developing and marketing scientifically formulated beauty and personal care products. Innovaderma PLC aims to address the growing demand for innovative and effective solutions in the beauty industry. With a strong emphasis on research and development, the company strives to deliver high-quality products that cater to a wide range of consumer needs. By leveraging its expertise and understanding of the market, Innovaderma PLC aims to create products that are both innovative and affordable, allowing consumers to enhance their beauty and well-being.

What is the P/E ratio of Innovaderma 2024?

The Innovaderma P/E ratio is 57.99.

What is the P/S ratio of Innovaderma 2024?

The Innovaderma P/S ratio is 0.44.

What is the Quality Investing of Innovaderma?

The Quality Investing for Innovaderma is 2/10.

What is the revenue of Innovaderma 2024?

The expected Innovaderma revenue is 11.54 M GBP.

How high is the profit of Innovaderma 2024?

The expected Innovaderma profit is 87,260.84 GBP.

What is the business model of Innovaderma

Innovaderma PLC is a company that focuses on providing effective, high-quality, and affordable beauty and body care products. The company is based in the United Kingdom and distributes its products worldwide. Innovaderma PLC has been listed on the AIM in the London Stock Exchange since 2016. The company is divided into three divisions, namely Beauty Devices, Topical Products, and Razor Subscription Program. Beauty Devices: Innovaderma PLC has developed a wide range of beauty devices that help regenerate and improve skin problems. The products are a combination of advanced technology and scientific knowledge. Currently, the company offers three beauty devices, namely TriPollar Stop, TriPollar Pose, and TriPollar Geneo. These devices have been specially designed to make the skin appear visibly smoother, firmer, and more youthful. Topical Products: Innovaderma PLC offers a wide range of topical products specifically designed to treat various skin problems. The products are rich in natural ingredients and allow customers to receive effective, safe, and affordable skincare. Currently, the company offers a wide range of topical products, including Skinny Tan, Roots, Hairfix, Stevie K, and Charles + Lee. Razor Subscription Program: Innovaderma PLC has developed a razor subscription program called Men's Shave. The program is designed to deliver high-quality shaving products to men's homes and make it easier for them to regularly purchase new razor blades. The subscription is seamless and offers customers a comprehensive experience by providing high-quality products, hassle-free service, and attractive value for money. Innovaderma PLC generates revenue through the sale of products and services. The company distributes its products online and in selected stores. The company's fan base is growing due to its affordable prices, high-quality products and services, user-friendly website, and strong presence on social media platforms. Innovaderma PLC aims to be a leading company in the beauty and body care industry and to remain innovative and competitive. The company invests in research and development to develop new and improved products that meet customer needs. Additionally, the company utilizes technological advancements and digital strategies to maximize its reach and directly interact with its customers. Innovaderma PLC is a company that focuses on innovation, quality, and customer satisfaction. It takes pride in being one of the top brands in the beauty and body care products industry. With a growing number of customers worldwide and a strong vision, Innovaderma PLC is well positioned to continue growing and succeeding in the market.

What is the Innovaderma dividend?

Innovaderma pays a dividend of 0 GBP distributed over payouts per year.

How often does Innovaderma pay dividends?

The dividend cannot currently be calculated for Innovaderma or the company does not pay out a dividend.

What is the Innovaderma ISIN?

The ISIN of Innovaderma is GB00BT9PTW34.

What is the Innovaderma WKN?

The WKN of Innovaderma is A14TML.

What is the Innovaderma ticker?

The ticker of Innovaderma is IDP.L.

How much dividend does Innovaderma pay?

Over the past 12 months, Innovaderma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Innovaderma is expected to pay a dividend of 0 GBP.

What is the dividend yield of Innovaderma?

The current dividend yield of Innovaderma is .

When does Innovaderma pay dividends?

Innovaderma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Innovaderma?

Innovaderma paid dividends every year for the past 0 years.

What is the dividend of Innovaderma?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Innovaderma located?

Innovaderma is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Innovaderma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Innovaderma from 11/3/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 11/3/2024.

When did Innovaderma pay the last dividend?

The last dividend was paid out on 11/3/2024.

What was the dividend of Innovaderma in the year 2023?

In the year 2023, Innovaderma distributed 0 GBP as dividends.

In which currency does Innovaderma pay out the dividend?

The dividends of Innovaderma are distributed in GBP.

All fundamentals about Innovaderma

Our stock analysis for Innovaderma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Innovaderma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.